Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.64B P/E - EPS this Y -234.70% Ern Qtrly Grth -
Income -125.45M Forward P/E -18.93 EPS next Y 43.20% 50D Avg Chg -2.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 7.00%
Dividend N/A Price/Book 5.89 EPS next 5Y - 52W High Chg -22.00%
Recommedations 1.60 Quick Ratio 8.45 Shares Outstanding 81.24M 52W Low Chg 252.00%
Insider Own 3.16% ROA -21.83% Shares Float 387.17M Beta 0.44
Inst Own 91.84% ROE -56.85% Shares Shorted/Prior 8.85M/10.70M Price 20.64
Gross Margin - Profit Margin - Avg. Volume 394,422 Target Price 35.79
Oper. Margin - Earnings Date Aug 8 Volume 185,167 Change -3.80%
About Verona Pharma plc

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Verona Pharma plc News
11/19/24 Verona Pharma Announces December 2024 Investor Conference Participation
11/05/24 Verona Pharma (NASDAQ:VRNA) shareholder returns have been incredible, earning 724% in 5 years
11/05/24 Verona Pharma PLC (VRNA) Q3 2024 Earnings Call Highlights: Strong Ohtuvayre Launch Amid Rising Costs
11/05/24 Verona Pharma to Present at Jefferies London Healthcare Conference
11/04/24 Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update
10/25/24 Recent Price Trend in Verona Pharma (VRNA) is Your Friend, Here's Why
10/25/24 Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma
10/24/24 5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright
10/21/24 Verona Pharma to Report Third Quarter 2024 Financial Results and Provide Corporate Update
10/11/24 Wall Street Analysts Think Verona Pharma (VRNA) Could Surge 25.25%: Read This Before Placing a Bet
10/09/24 Verona Pharma (VRNA) Is a Great Choice for 'Trend' Investors, Here's Why
09/30/24 Verona Pharma to Present Six Analyses of theย Phase 3 ENHANCE Studies in COPD at CHEST 2024
09/14/24 Insider Sale: CFO Mark Hahn Sells 600,000 Shares of Verona Pharma PLC (VRNA)
09/14/24 Verona Pharma PLC (VRNA) CEO David Zaccardelli Sells 600,000 Shares
09/05/24 Verona Pharma to Present Additional Analyses of Phase 3 ENHANCE Studies in COPD at ERS International Congress 2024
08/14/24 Insider Sale: CFO Mark Hahn Sells 400,000 Shares of Verona Pharma PLC (VRNA)
08/09/24 Is Verona Pharma plc (VRNA) a Good Addition to Your Portfolio Now?
08/08/24 Verona Pharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update
08/03/24 Verona Pharma plc's (NASDAQ:VRNA) Path To Profitability
07/30/24 Verona Pharma to Present at 44th Annual Canaccord Growth Conference
VRNA Chatroom

User Image investak Posted - 6 hours ago

$VRNA $50 in sight

User Image MakeMoneyAZ Posted - 9 hours ago

$VRNA someone knows something

User Image Kingjake26 Posted - 12 hours ago

$VRNA nice day. :))

User Image JimmyBoomBoom Posted - 13 hours ago

$VRNA You magnificent beast.

User Image MakeMoneyAZ Posted - 13 hours ago

$VRNA t minus 12 days. Til my guess of a buyout

User Image BDE_Worldwide Posted - 13 hours ago

$VRNA wants to find a new home above $40! Great to see! ๐Ÿš€ Just wish I had bought more.. no brainer in hindsight..

User Image 7Billiards Posted - 14 hours ago

$VRNA you beauty

User Image BigFella2021 Posted - 14 hours ago

$CAPR $VRNA now weโ€™re talking!! Letโ€™s go George Jefferson!!!! ๐Ÿ™๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ˜Ž

User Image Trainguy1 Posted - 16 hours ago

$VRNA If you are a baby boomer or from the early years of generation X, you should well remember life before the internet. We retail investors had to get stock prices and business news from the newspaper, which was at best available the morning after the stock market close. And if you wanted to buy or sell, you had to spend some time on the phone with your stockbroker, who normally charged 3% commission for all trades. I think those conditions made it easier to buy and hold without trying to time the market. If you were born more recently, I suggest that you model life before the internet as it pertains to stock trades. You just might experience less aggravation, and come out with more profit in the end.

User Image BigFella2021 Posted - 16 hours ago

$VRNA $CAPR Anyone in here remember the TV show โ€œThe Jeffersonโ€™sโ€? Thatโ€™s the theme song we need to keep in mind for VRNA and CAPR! ๐Ÿ™๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ˜Ž

User Image Airmiles8 Posted - 18 hours ago

$VRNA

User Image Milanfinest Posted - 1 day ago

$VRNA good day to add, is accumulating, even if pulls back to 35- rr is -20 /+ 100 and more %

User Image TPapreee Posted - 1 day ago

$VRNA Fine ill buy some more

User Image MakeMoneyAZ Posted - 1 day ago

$VRNA figuratively zero buys today.

User Image BigFella2021 Posted - 1 day ago

$VRNA maybe another run at $40? Maybe? ๐Ÿ˜

User Image Prosperity1_ Posted - 1 day ago

@Rungreen $vrna That article was posted in June before their launch. Their launch has been a super success with the drug quickly being adopted by physicians.

User Image Rungreen Posted - 1 day ago

$VRNA very interesting and I see this is your first post on VRNA. Thanks for bringing this to our attention.

User Image Milanfinest Posted - 1 day ago

$VRNA 45 end december?

User Image TPapreee Posted - 1 day ago

$VRNA $40 today?!? Seems like this thing does not like $40 at all right now but once it breaks through sky is the limit

User Image MakeMoneyAZ Posted - 1 day ago

$VRNA T minus 13 trading days. Lets gooooo!!!!!!

User Image rubraquercus Posted - 1 day ago

$VRNA https://seekingalpha.com/article/4701660-verona-pharma-launching-ohtuvayre-there-will-be-competition?source=feed_f&utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated

User Image Datum Posted - 1 day ago

$VRNA oof, $40 premarket

User Image GXD_Texas Posted - 1 day ago

$VRNA thatโ€™s a first

User Image 10baggers Posted - 1 day ago

$VRNA I am smelling something ๐Ÿ‘จโ€๐Ÿณ๐Ÿฅ˜

User Image investak Posted - 1 day ago

$VRNA https://www.veronapharma.com/wp-content/uploads/2024/11/VRNA-Presentation-November-2024.pdf November presentation for World COPD day. It doesn't seem like anything is updated tho

User Image investak Posted - 1 day ago

$VRNA damn what's going on today

User Image marked0ne Posted - 1 day ago

$VRNA +7% in Europe already. โ‚ฌ39, which translates to $41!!!

User Image GXD_Texas Posted - 2 days ago

$VRNA ๐Ÿ‘๐Ÿผ

User Image BigFella2021 Posted - 2 days ago

$VRNA Great day, fellow VRNA bulls. Such a terrific company and product. Incredible efficacy. I really believe this either works its way up to $100+ within 18 months, or it gets bought out sooner for about the same price. ๐Ÿ™๐Ÿ‡บ๐Ÿ‡ธ๐Ÿ˜Ž

User Image Zip74 Posted - 2 days ago

$VRNA last trade on Nasdaq was $39.50

Analyst Ratings
HC Wainwright & Co. Buy Oct 1, 24
HC Wainwright & Co. Buy Sep 17, 24
HC Wainwright & Co. Buy Sep 11, 24
Canaccord Genuity Buy Jul 22, 24
HC Wainwright & Co. Buy Jul 1, 24
Truist Securities Buy Jun 28, 24
Canaccord Genuity Buy Jun 27, 24
HC Wainwright & Co. Buy Jun 27, 24
HC Wainwright & Co. Buy May 15, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Feb 01 Sell 2.22 36,248 80,471 2,731,624 02/05/24
Edwards Martin Director Director Nov 20 Buy 1.8370 33,736 61,973 144,800 11/22/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Nov 01 Sell 1.92 58,752 112,804 2,840,640 11/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Aug 03 Sell 2.51 80,144 201,161 2,872,528 08/07/23
ZACCARDELLI DAVID President and CEO President and CEO Aug 03 Sell 2.5 275,888 689,720 16,431,800 08/07/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Aug 03 Sell 2.5 275,888 689,720 15,521,248 08/07/23
Poll Claire General Counsel General Counsel Aug 03 Sell 2.5 48,472 121,180 1,907,367 08/07/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Aug 01 Sell 2.64 179,648 474,271 15,797,136 08/03/23
Poll Claire General Counsel General Counsel Aug 01 Sell 2.64 31,552 83,297 1,955,839 08/03/23
ZACCARDELLI DAVID President and CEO President and CEO Aug 01 Sell 2.64 179,648 474,271 16,707,688 08/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Aug 01 Sell 2.64 33,464 88,345 2,952,672 08/03/23
ORBIMED ADVISORS LLC Director Director May 11 Sell 21.47 482,913 10,368,142 3,777,778 05/15/23
Gupta Rishi Director Director May 11 Sell 21.47 482,913 10,368,142 3,777,778 05/15/23
Poll Claire General Counsel General Counsel May 01 Sell 2.5759 80,376 207,041 1,979,063 05/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer May 01 Sell 2.61 106,176 277,119 2,971,136 05/03/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer May 01 Sell 2.5759 455,528 1,173,395 15,976,784 05/03/23
ZACCARDELLI DAVID President and CEO President and CEO May 01 Sell 2.5759 455,536 1,173,415 16,887,336 05/03/23
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 2.5572 413,168 1,056,553 16,432,312 02/03/23
ZACCARDELLI DAVID President and CEO President and CEO Feb 01 Sell 2.5572 432,928 1,107,083 17,342,872 02/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Jan 20 Sell 2.54 118,712 301,528 3,077,312 02/03/23
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Jan 20 Option 0 105,000 3,196,024 02/03/23
Poll Claire General Counsel General Counsel Jan 20 Sell 2.59 152,000 393,680 774,256 02/03/23
Poll Claire General Counsel General Counsel Jan 20 Option 0 178,800 2,211,439 02/03/23
Poll Claire General Counsel General Counsel Nov 21 Sell 2.69 240,000 645,600 774,256 12/27/22
ORBIMED ADVISORS LLC Director Director Dec 22 Sell 22.68 6,139,864 139,252,116 34,085,528 12/27/22
Gupta Rishi Director Director Dec 22 Sell 22.68 6,139,864 139,252,116 34,085,528 12/27/22
ZACCARDELLI DAVID President and CEO President and CEO Aug 09 Sell 1.75 600,000 1,050,000 15,263,560 08/11/22
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Aug 09 Sell 1.75 600,000 1,050,000 14,313,496 08/11/22
ZACCARDELLI DAVID President and CEO President and CEO May 03 Sell 0.4956 32,904 16,307 16,351,328 05/05/22
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer May 03 Sell 0.4923 28,752 14,155 2,461,224 05/05/22
Hahn Mark W Chief Financial Offi.. Chief Financial Officer May 03 Sell 0.4956 12,512 6,201 15,381,520 05/05/22
Rickard Kathleen A. Chief Medical Office.. Chief Medical Officer Apr 08 Sell 0.56 172,520 96,611 2,546,408 04/12/22
Deschamps Lisa Director Director Feb 01 Sell 0.7775 11,664 9,069 70,320 02/03/22
ZACCARDELLI DAVID President and CEO President and CEO Feb 01 Sell 0.73 52,056 38,001 16,839,096 02/03/22
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Feb 01 Sell 0.76 10,416 7,916 15,826,160 02/03/22
ZACCARDELLI DAVID President and CEO President and CEO Nov 01 Sell 0.64 52,056 33,316 16,845,352 11/03/21
Hahn Mark W Chief Financial Offi.. Chief Financial Officer Nov 01 Sell 0.65 10,416 6,770 15,991,120 11/03/21